Insider Selling: Omada Health (NASDAQ:OMDA) CFO Sells $656,370.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 33,000 shares of the business’s stock in a transaction on Friday, June 26th. The shares were sold at an average price of $19.89, for a total transaction of $656,370.00. Following the sale, the chief financial officer owned 133,359 shares in the company, valued at approximately $2,652,510.51. This trade represents a 19.84% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Omada Health Price Performance

Shares of Omada Health stock opened at $22.39 on Friday. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The firm has a market cap of $1.33 billion and a price-to-earnings ratio of -82.93. The company has a 50-day moving average of $17.16 and a 200 day moving average of $15.03.

Omada Health (NASDAQ:OMDA) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. The business had revenue of $78.05 million for the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. On average, equities analysts anticipate that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Investors Weigh In On Omada Health

Several institutional investors and hedge funds have recently made changes to their positions in the company. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Omada Health during the 4th quarter valued at $1,222,000. Divisadero Street Capital Management LP bought a new stake in shares of Omada Health in the 3rd quarter worth $30,510,000. a16z Perennial Management L.P. purchased a new position in shares of Omada Health in the fourth quarter worth $2,480,000. Madryn Asset Management LP bought a new position in shares of Omada Health during the fourth quarter valued at $9,212,000. Finally, Parallel Advisors LLC lifted its holdings in shares of Omada Health by 12,235.9% during the fourth quarter. Parallel Advisors LLC now owns 123,359 shares of the company’s stock valued at $1,947,000 after purchasing an additional 122,359 shares in the last quarter.

Wall Street Analyst Weigh In

Several research firms recently weighed in on OMDA. Wells Fargo & Company upped their price target on Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Barclays lifted their price objective on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Citizens Jmp increased their target price on Omada Health from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research note on Friday, May 8th. BMO Capital Markets reduced their price target on Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a report on Friday, March 6th. Finally, Canaccord Genuity Group set a $24.00 price target on Omada Health in a research report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $22.91.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.